Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.16 USD | -3.97% | -3.28% | -15.04% |
14/05 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.04% | 231M | |
+26.36% | 451B | |
+34.42% | 280B | |
+5.46% | 133B | |
+7.66% | 93.33B | |
+25.50% | 92.61B | |
+63.65% | 61.54B | |
+12.90% | 45.98B | |
+22.96% | 36.9B | |
-8.34% | 34.01B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Piper Sandler Adjusts Price Target on OptimizeRx to $16 From $29, Maintains Neutral Rating